poisar

Stock

MetLife, Inc. MET

$92.61-0.40%

Overview

MET market data

Price History

MET price chart

Valuation & Profitability

Alpha Vantage
P/E (TTM)
17.49
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
9.90
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$5.24
Diluted earnings per share over the trailing twelve months.
Beta
0.78
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
2.5%
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
4.7%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$66.82 – $92.27
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
$92.94
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Alpha Vantage OVERVIEW · market cap $59B · P/B 2.12 · P/S 0.75.

Company news

10 captured
TD Cowen Maintains Buy on MetLife, Raises Price Target to $105Benzinga · Jul 22, 2026, 5:44 PM
JP Morgan Maintains Overweight on MetLife, Raises Price Target to $106Benzinga · Jul 21, 2026, 3:30 PM
Evercore ISI Group Maintains In-Line on MetLife, Raises Price Target to $103Benzinga · Jul 13, 2026, 5:18 PM
Keefe, Bruyette & Woods Maintains Outperform on MetLife, Raises Price Target to $105Benzinga · Jul 13, 2026, 1:18 PM
Jefferies Maintains Buy on MetLife, Raises Price Target to $103Benzinga · Jul 10, 2026, 1:55 PM
Wells Fargo Maintains Overweight on MetLife, Raises Price Target to $101Benzinga · Jul 9, 2026, 6:15 PM
Mizuho Maintains Outperform on MetLife, Raises Price Target to $102Benzinga · Jul 9, 2026, 1:20 PM
UBS Maintains Buy on MetLife, Raises Price Target to $105Benzinga · Jul 8, 2026, 6:50 PM
Barclays Maintains Overweight on MetLife, Raises Price Target to $94Benzinga · Jul 7, 2026, 5:05 PM
Morgan Stanley Maintains Overweight on MetLife, Raises Price Target to $103Benzinga · Jul 6, 2026, 2:05 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock